Trimeric OX40-immunoglobulin fusion protein and methods of use

Document Type

Patent

Publication Date

11-13-2009

Abstract

Compositions including a trimeric OX-40 fusion protein are disclosed. Also disclosed are methods for enhancing the immune response of a mammal to an antigen by engaging the OX-40 receptor on the surface of T-cells involving administering to the mammal a composition comprising a trimeric OX-40 fusion protein and a pharmaceutically acceptable carrier.

Specialty/Research Institute

Earle A. Chiles Research Institute

Location

United States

Comments

Patent Number: 7,959,925

Assignee

Providence Health System (Seattle, WA)

Family ID

37397109

Serial Number

12/618,678

Tech ID

05-02-INV-F

Link to Full Text

Share

COinS